Irmandade Santa Casa de Misericordia de Porto Alegre | Oncology

São Paulo, São Paulo 90020-090

1 studies enrolling now · 2 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, Cancer

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling